Discontinued — last reported Q4 '25
Accrued Expenses
Current LiabilitiesJohnson & Johnson Accrued Expenses increased by 2.7% to $7.60B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 33.6%, from $11.45B to $7.60B. Over 3 years (FY 2021 to FY 2024), Accrued Expenses shows a downward trend with a -14.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2008
Last reportedQ4 2025
How to read this metric
Rising accruals often track with headcount growth or increased operational activity.
Detailed definition
Liabilities representing expenses that have been incurred but not yet paid or invoiced, such as employee wages, interest...
Peer comparison
Standard across all industries; usually scales linearly with the size of the workforce and operations.
Metric ID:
accrued_expensesHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.22B | $10.49B | $13.81B | $13.61B | $13.01B | $12.61B | $11.46B | $11.20B | $10.10B | $10.21B | $10.32B | $10.54B | $11.45B | $8.55B | $7.91B | $7.40B | $7.60B |
| QoQ Change | — | -20.7% | +31.7% | -1.4% | -4.5% | -3.1% | -9.1% | -2.2% | -9.8% | +1.1% | +1.1% | +2.1% | +8.6% | -25.3% | -7.4% | -6.4% | +2.7% |
| YoY Change | — | — | — | — | -1.6% | +20.2% | -17.1% | -13.9% | -19.9% | -10.9% | — | -5.9% | +13.4% | -16.3% | -23.3% | -29.7% | -33.6% |
Range$7.40B – $13.81B
CAGR-12.9%
Avg YoY Growth-11.6%
Median YoY Growth-15.1%
Accrued Expenses at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's accrued expenses?
- Johnson & Johnson (JNJ) reported accrued expenses of $7.60B in Q3 2025.
- How has Johnson & Johnson's accrued expenses changed year-over-year?
- Johnson & Johnson's accrued expenses decreased by 33.6% year-over-year, from $11.45B to $7.60B.
- What is the long-term trend for Johnson & Johnson's accrued expenses?
- Over 3 years (2021 to 2024), Johnson & Johnson's accrued expenses has grown at a -14.8% compound annual growth rate (CAGR), from $13.81B to $8.55B.
- What does accrued expenses mean?
- Costs the company has run up but hasn't received a bill for yet.